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OBJECTIVE
Despite its growing prevalence in China, the extent to which diabetes leads to
excess cardiovascular disease (CVD) mortality and all-cause mortality is unclear.
RESEARCH DESIGN AND METHODS
We compared death rates and causes of death among 630 people with newly
diagnosed diabetes (NDD) and 519 with normal glucose tolerance (NGT) who, in
1986, were identiﬁed as a result of screening 110,660 adults aged 25–74 years for
diabetes in Da Qing, China.
RESULTS
During 23 years of follow-up, 338 (56.5%) participants with NDD and 100 (20.3%)
with NGT died. CVD was the predominant cause of death in those with diabetes
(47.5% in men and 49.7% in women), almost half of which was due to stroke
(52.3% in men and 42.3% in women). The age-standardized incidence of all-cause
death was three times as high in those with NDD as in those with NGT with
incidences (per 1,000 person-years) of 36.9 (95% CI 31.5–42.3) vs. 13.3 (10.2–
16.5) in men (P < 0.0001) and 27.1 (22.9–31.4) vs. 9.2 (7.8–10.6) in women (P <
0.0001). The incidence of CVD deaths in men and women with NDD (17.5 [13.8–
21.2] vs. 13.5 [10.5–16.5]) did not differ signiﬁcantly. Signiﬁcantly higher death
rates attributable to renal disease and infectionwere also found in theNDD group.
CONCLUSIONS
Diabetes is associated with a substantially increased risk of death in Chinese
adults, especially from CVD, almost half of which is due to stroke.
In 2010, an estimated 113.9 million adults in China had diabetes (1,2). Whereas
excess risk for death among people with diabetes has been well documented in
Western populations (3–8), much less information is available in Asian populations,
especially in China (5,9–11). Much of the increased risk in Europeans has been
attributed to cardiovascular disease (CVD), especially myocardial infarction and
heart failure, but also to stroke, renal disease, and infection. Excessmortality related
to diabetes has been reported in Chinese origin populations in Singapore, Taiwan, and
Mauritius (9,11,12), but the relationship has not been assessed through population-
based studies in the Chinese mainland where the only relevant data come from a
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few short-term studies of hospital-
based clinic patients (13,14). We pres-
ent mortality data from Da Qing, China,
comparing the incidence and causes of
death in people who in 1986 had newly
diagnosed diabetes (NDD) or normal
glucose tolerance (NGT) and who were
followed up for 23 years.
RESEARCH DESIGN AND METHODS
In 1986, the Da Qing IGT and Diabetes
Study was conducted to determine the
prevalence of diabetes and associated
characteristics among residents of Da
Qing, China, a city to which people
from all areas of China had migrated
since 1960 (15,16). In 1986, Da Qing
had 281,589 residents aged 25–74 years
who received health care in designated
clinics located throughout the city. Res-
idents assigned for care in half of these
clinics were selected to be eligible for
screening for diabetes. Plasma glucose
levels were measured in 110,660 sub-
jects (87.3% of the eligible study popu-
lation; 55,391 men and 55,269 women)
2 h (65 min) after each had consumed a
standardized breakfast consisting of a
100-g steamed bread bun containing
;80 g of carbohydrate. Those without
previously diagnosed diabetes and with
2-h plasma glucose levels $6.7 mmol/L
(n = 4,209) after the standard meal were
invited to have a 75-g oral glucose toler-
ance test (OGTT), which included mea-
surement of fasting and 2-h postload
plasma glucose levels, and 3,956 partic-
ipants (94.0%) received this test (15,17).
Based on the OGTT results classiﬁed by
1985 World Health Organization (WHO)
criteria (18), 630 participants (300 men
and 330 women) were identiﬁed as hav-
ing NDD (deﬁned as 2-h plasma glucose
level $11.1 mmol/L).
To determine the effect of diabetes
on mortality, we compared death rates
in the NDD group to those in a group of
519 people (282 men and 237 women)
who had participated in the diabetes
screening and had the 75-g OGTT but
with NGT, deﬁned as 2-h plasma glucose
level,6.7mmol/L. From these subjects,
the group with NGT was randomly se-
lected, by frequency matching, to be of
comparable sex, age-group, and size to
that of the group with impaired glucose
tolerance who subsequently partici-
pated in the Da Qing Diabetes Preven-
tion Study (15,19,20). The NGT group
had the same baseline age range as
the NDD group (25–74 years) but, on
average, was somewhat younger.
All participants in the NDD and NGT
groups received a baseline examination
that included measurements of blood
pressure, BMI, a 12-lead electrocardio-
gram, and plasma lipids. Details of the
methods used have been published pre-
viously (15,17). Those with diabetes were
informed of the diagnosis and referred to
their local clinics for continuing medical
care, during which most were treated
with oral hypoglycemic agents or insulin.
In 2009, we conducted a follow-up
study to determine mortality rates and
causes of death among both groups of
participants. Institutional review boards
at WHO and the China-Japan Friendship
Hospital approved the study. All surviving
study participants and the proxies who
served as informants for deceased partic-
ipants gave written informed consent.
Data Collection
In 2009, we attempted to recontact
each participant to determine their vital
status. For deceased participants, a ver-
bal autopsy was conducted by inter-
viewing an informant to determine the
date, place, and circumstances of death.
The informant was also asked to provide
information on hospitals, clinics, and
physicians where the participant had re-
ceived medical care around the time of
death. The death certiﬁcates, medical
records, and the informant interviews
were reviewed and adjudicated inde-
pendently by two physicians, blinded
to the participant’s 1986 glucose status,
to determine the underlying cause of
death. Disagreements were resolved
by a third senior physician (19–21).
Outcome Classiﬁcation
We classiﬁed underlying causes of death
as due to either CVD, which included
coronary heart disease (CHD) (myocar-
dial infarction, sudden death, or con-
gestive heart failure) and stroke, or
noncardiovascular causes (non-CVD),
which included cancer, renal failure, in-
fections, diabetes-related complications
(diabetic ketoacidosis or hyperglycemic
hyperosmolar coma), chronic obstruc-
tive pulmonary disease, cirrhosis, injury
(trafﬁc accidents or work-related inju-
ries), and unknown.
Statistical Analyses
The follow-up period was from 1 Janu-
ary 1986 until date of death or 31
December 2009 for those still alive. For
those lost to follow-up, the period was
truncated to the date of last contact.
Death rates and their 95% CIs are ex-
pressed as the number of deaths divided
by the number of person-years at risk,
and relative differences in rates be-
tween groups are shown as hazard ra-
tios (HRs) and 95% CI. To control for the
difference in age distribution between
the NDD and NGT groups, rates and CIs
were standardized to the age distribu-
tion in the NDD group calculated using
the SAS STDRATE procedure. We used
Cox proportional hazards regression to
obtain the direct age-adjusted survival
curve by averaging the estimated sur-
vival curves for the observations in the
original data (22). Multivariable models
adjusted for age, sex, and other CVD risk
factors (BMI, blood pressure, smoking,
plasma total cholesterol, and previous
history of CVD) were used to determine
the inﬂuence of these factors on all-
cause and CVD mortality rates using
Cox proportional hazards models. We
used the multiple imputation method
to impute the missing values for total
serum cholesterol. The imputation
model included all dependent and inde-
pendent variables of models in comput-
ing the missing values. Fifty sets of
multiple imputed data were generated
to provide an adequate level of repro-
ducibility of the multiple imputation
analysis (22). Differences were consid-
ered statistically signiﬁcant if two-sided
P values were ,0.05. Data manage-
ment, multiple imputation, and analyses
were performed using SAS version 9.4
(SAS, Cary, NC).
RESULTS
Vital status and cause of death were de-
termined in 598 (94.9%) participants
with NDD and 492 (94.8%) with NGT.
At baseline, men and women with NDD
were, on average, up to 5 years older
than those with NGT (Table 1 and Sup-
plementary Table 1). BMI and blood
pressure were higher in those with
NDD than in those with NGT. The pro-
portion of smokers was much higher in
men (59.0 and 67.3%) than in women
(12.7 and 18.6%).
Figure 1A and B shows the age-
adjusted cumulative incidence of deaths
in the NDD and NGT groups according
to sex and length of follow-up, which,
in the NDD group, reﬂects duration of
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diabetes. The cumulative incidence rises
more steeply in both men and women
with NDD than in the NGT groups. The
cumulative incidence of death in women
with NGT is lower than in men, whereas
in women with NDD, it approaches the
levels seen in men with NDD. By the end
of the 23-year follow-up, 338 (56.5%)
with NDD and 100 (20.3%) who originally
had NGT had died.
Table 2 shows underlying causes of
death and age-standardized death rates
in the NGT and NDD groups by sex. The
relative risk of death from all causes was
three times as high in the NDD group as
in those with NGT. The age-adjusted in-
cidence of all-cause mortality averaged
36.9/1,000 person-years in the NDD vs.
13.3 in the NGT group (P , 0.0001) in
men, and in women, the rates were 27.1
vs. 9.2/1,000 person-years, respectively
(P , 0.0001).
CVD was the most common cause of
death in the NDDs, accounting for 47.5%
of deaths in men and 49.7% in women.
The CVD mortality rates in the men and
women with NDD (17.5 vs. 13.5/1,000
person-years) did not differ signiﬁ-
cantly. CHD accounted for 47.7% of the
CVD deaths in men and 57.7% in women
with NDD, and the age-standardized
CHD mortality rates (8.4 in men vs.
7.8/1,000 person-years in women)
were almost identical. In contrast,
among those with NGT, CVD mortality
rates were much lower (5.3 in men and
3.5/1,000 person-years in women).
Stroke also accounted for a large pro-
portion of CVD-related deaths in both
men (52.3%) and women (42.3%) with
diabetes. Age-adjusted mortality rates
attributed to stroke in the NDD group,
compared with their same-sex counter-
parts with NGT, were four times higher
among men (9.2 vs. 2.0/1,000 person-
years, P , 0.001) and twice as high
among women (5.7 vs. 3.0/1,000
person-years, P , 0.05).
Some of the non-CVD causes of death
also were more frequent in the NDD
than in the NGT group. Most deaths at-
tributed to renal failure (52/55; 94.5%)
occurred in the NDD group, with a sim-
ilar incidence among men and women
(4.9 vs. 4.8/1,000 person-years). Deaths
attributed primarily to infection oc-
curred in 28 (4.7%) of the NDD group
but in only 4 (0.8%) of the NGT group,
with an incidence of 2.6 and 0.4/1,000
person-years, respectively (P , 0.001).
Death from cancer occurred in 48 (8.0%)
participants with NDD and 41 (8.3%)
participants with NGT, with death rates
per 1,000 person-years of 5.7 vs. 5.3 in
men and 3.5 vs. 2.7 in women, respec-
tively. After adjusting for differences in
other risk factors (sex, BMI, and
smoking), a small but nonsigniﬁcant in-
crease in death rates due to cancer was
seen among those with NDD (HR 1.2, P =
0.4).
To determine if the effect of diabetes
on excess CVD mortality was attribut-
able to diabetes itself, or if the excess
could be explained by the presence of
other risk factors, multivariable models
were used to adjust for other potential
cardiovascular risk factors. Table 3
shows adjusted HRs for all-cause and
CVD deaths. After adjusting for age,
sex, baseline BMI, systolic blood pres-
sure (SBP), smoking, plasma total cho-
lesterol, and previous history of CVD,
the risk of death in those with NDD re-
mained signiﬁcantly higher than within
the NGT group (HR 3.5 for CVD and 3.1
for all-cause deaths), and among
women the HRs (HR 5.9 for CVD and
4.1 for all-cause deaths) were higher
than among the men (HR 2.7 for CVD
and 2.6 for all-cause deaths).
At the beginning of follow-up, both
the NDD and NGT groups had a wide
age range and those with NDD had large
variations in age at diagnosis, and over
the 23-year follow-up, age and duration
of diabetes increased. To examine the
inﬂuence of each of these factors (aging,
age at onset of diabetes, and duration of
diabetes) on the likelihood of death, we
calculated age-speciﬁc and duration-
speciﬁc death rates (Tables 4 and 5).
All-cause and CVD mortality rates in-
creased with age in the NGT and NDD
groups, and in the group with NDD, they
increased with time since diagnosis
within each age-group (except those
aged over 70 years with 15 or more
years’ duration). Age-adjusted all-cause
death rates were four times and CVD
death rates were seven times higher
among those with a diabetes duration
of 15 or more years than in those who
had diabetes for ,5 years. Similar pat-
terns were seen in both men and
women (Supplementary Tables 2–5).
Thus, longer duration of diabetes, age
of onset, and current age each contrib-
uted independently to the excess risk of
death in those with diabetes.
Table 1—Baseline characteristics by glucose tolerance group of participants whose vital status was ascertained in 2009
NDD (n = 598) NGT (n = 492)
Men (n = 290) Women (n = 308) Men (n = 272) Women (n = 220)
Age (years) 50.0 6 8.6 46.6 6 8.5 45.9 6 9.3 41.6 6 7.9
BMI (kg/m2) 25.1 6 3.4 26.0 6 3.8 23.5 6 3.4 23.9 6 3.3
Fasting plasma glucose (mmol/L) 8.4 6 2.7 8.8 6 3.3 4.8 6 0.8 4.7 6 0.5
1-h plasma glucose (mmol/L)* 15.9 6 3.3 16.1 6 3.7 6.9 6 1.5 6.5 6 1.4
2-h plasma glucose (mmol/L)† 15.1 6 3.5 15.5 6 3.7 4.9 6 1.3 5.2 6 0.9
SBP (mmHg) 137.6 6 24.2 133.4 6 23.3 123.9 6 20.3 120.8 6 22.5
Diastolic blood pressure (mmHg) 89.1 6 13.9 87.1 6 14.8 82.9 6 12.8 80.7 6 15.2
Cholesterol (mmol/L) 5.40 6 1.67 5.24 6 1.59 4.90 6 1.11 4.70 6 1.12
Triglyceride (mmol/L) 2.08 6 1.90 2.16 6 2.44 1.36 6 1.08 1.24 6 0.95
Smokers (%) 59.0 12.7 67.3 18.6
CVD (%) 2.76 1.95 0 0.45
Data are means 6 SD or % of participants in each group. *Venous plasma glucose concentration 1 h after 75-g oral glucose load; †venous plasma
glucose concentration 2 h after 75-g oral glucose load.
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Death below 70 years of age occurred
in 223 (66.0%) people with NDD who
died compared with 55 people with
NGT, with age-adjusted death rates of
20.9 vs. 5.6/1,000 person-years, respec-
tively (P, 0.001) (Table 4). Thus, diabe-
tes was associated with more than a
threefold increase in premature mortal-
ity, much of which was attributable to
death from CVD, in this mainland Chi-
nese population.
CONCLUSIONS
Although diabetes is a well-established
risk factor for all-cause death and CVD
death, few population-based studies
have examined the risk for death in peo-
ple with NDD who were followed over a
long time period (12,23–25). This is the
ﬁrst study to do so in China. During the
23-year follow-up, .50% the partici-
pants with NDD died, and half of them
died of CVD. However, only 20%of those
with NGT died, of whom 37% died of
CVD. The age-adjusted relative risk of
death from all causes in those with di-
abetes was three times as high as in
NGT. The differences in relative risk for
all-cause death and CVD death re-
mained signiﬁcant and largely un-
changed after controlling for baseline
smoking status and other CVD risk fac-
tors. These results indicate that the ex-
cess mortality seen in the NDD group
was largely due to the effect of diabetes
and was not primarily attributable to
differences in other cardiovascular risk
factors in the NDD and NGT groups.
Death rates in those with diabetes
were higher in those with longer
duration of diabetes within each age-
group, so that at any given age, the
risk of death was greater among those
who had an earlier age of onset. Conse-
quently, delaying the onset of diabetes
may reduce the likelihood of death, an
observation that provides the basis and
strong rationale for diabetes prevention
programs. As predicted, the Da Qing Di-
abetes Prevention Study has recently
shown that delaying the onset of diabe-
tes does indeed reduce CVD and all-
cause mortality (21).
In China, as in most countries, mortal-
ity rates, especially CVD mortality, are
higher in men than women. In Western
countries, CVD risk among women with
diabetes is disproportionately increased
with death rates that are similar to those
in men without diabetes (6,26). We
found a similar pattern of death from
CVD in China with similar CVD death
rates in men and women with diabetes
and with relatively disproportionate in-
creases in the women. Compared with
those with NGT, CVD-related mortality
in those with diabetes, adjusted for
other cardiovascular risk factors, was
2.7-fold higher in men and 5.9-fold
higher in women. Notably, in this study,
almost half of the diabetes-associated
excess CVD mortality was attributable to
stroke, whereas in Western countries, a
greater proportion is attributable to heart
disease.
Our study also demonstrates that di-
abetes changes the pattern of underly-
ing causes of death in the population.
Among people with NGT, cancer ac-
counted for 40% of all deaths, compara-
ble to the 37% due to CVD. However, in
those with NDD, although the cancer
death rate was similar to that in NGT,
only 14% of the deaths were due to can-
cer and CVD accounted for 48.5%. This
excess of cardiovascular and other
causes of premature death represent
competing causes for death from can-
cer. Premature death from CVD in sub-
jects with diabetes reduced the
likelihood of subsequent deaths due to
cancer, which would have occurred if
those with diabetes had survived to
older ages.
Consistent with our study ﬁndings,
Chinese people with diabetes in Taiwan
also have excess mortality when com-
pared with the general population (9).
The main cause of death was CVD, also
with half of CVD deaths due to stroke.
Figure 1—A: Age-adjusted cumulative incidence and age-adjusted HRs of death from all causes
in men and women with NGT and NDD over the 23 years of follow-up (white circles, men with
NDD; black circles, women with NDD; white squares, men with NGT; black squares, women with
NGT). B: Age-adjusted cumulative incidence and age-adjusted HRs of death from CVD inmen and
women with NGT and NDD over the 23 years of follow-up (white circles, men with NDD; black
circles, women with NDD; white squares, men with NGT; black squares, women with NGT).
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However, CVD death in the Chinese di-
abetes population in Taiwan only ac-
counted for 20% of deaths, which is
much less than we found in the main-
land Chinese, whereas the proportion
who died of cancer in Taiwan appears
higher than in our study (20 vs. 14%). In
the Chinese population residing in Maur-
itius, comparing those with diabetes to
NGT, the relative risk of mortality was
lower than seen in our study (12). In the
Chinese Mauritians, the HR for all-cause
mortality was 2.0 in men and 1.6 in
women compared with 2.6 in men and
4.1 in women in our study. For CVDmor-
tality, the ratio in Mauritians was 2.0 in
men and 1.8 in women compared with
2.7 in men and 5.9 in women in our
study. Reasons for the higher relative
mortality rates in our study and for the
difference by sex are not clear. The
higher rates in our study may be the re-
sult of longer follow-up than reported in
most other studies as death rates in-
crease and the pattern of causes of
death vary with age and increasing dia-
betes duration. It also seems likely that
differences in living environments and
variations in medical care may lead to
different mortality rates and differences
in the pattern of underlying causes of
death evenwithin the same ethnic group.
A study published in 2010 reported
that .1 million excess deaths per year
in China are attributable to diabetes,
roughly a quarter of the annual number
of such deaths worldwide (27). How-
ever, these estimates are based largely
on results from small hospital-based
studies or on data from Chinese not liv-
ing in mainland China. Our results, with
data from a relatively large, population-
based study, should help provide better
and more representative estimates of
the excess deaths that are attributable
to diabetes in mainland China. Our re-
sults show that diabetes is associated
with a death rate three times as high
Table 2—Death rates (per 1,000 person-years) in men and women according to baseline glucose tolerance groups
NDD NGT*
Men (n = 290) Women (n = 308) Men (n = 272) Women (n = 220)
pyrs = 4,908 pyrs = 5,787 pyrs = 5,734 pyrs = 4,886
n Rate# (95% CI) n Rate# (95% CI) n Rate# (95% CI) n Rate# (95% CI)
CVD 86 17.5 (13.8–21.2) 78 13.5 (10.5–16.5) 29 5.3 (3.3–7.2) 8 3.5 (0.9–6.1)
CHD 41 8.4 (5.8–10.9) 45 7.8 (5.7–10.4) 18 3.3 (1.8–4.9) 1 0.3 (0.2–1.1)
Stroke 45 9.2 (6.5–11.8) 33 5.7 (3.8–7.6) 11 2.0 (0.8–3.1) 7 3.0 (0.6–5.4)
Non-CVD 95 19.4 (15.5–23.2) 79 13.7 (10.6–16.7) 43 8.1 (5.6–10.5) 20 5.7 (2.7–8.7)
Cancer 28 5.7 (3.6–7.8) 20 3.5 (2.1–5.3) 28 5.3 (3.3–7.2) 13 2.7 (1.5–4.4)
Renal failure 24 4.9 (3.1–7.3) 28 4.8 (3.2–7.0) 2 0.4 (0–1.5) 1 0.2 (0–1.1)
Infection 18 3.7 (2.2–5.8) 10 1.7 (0.8–3.2) 3 0.6 (0.1–1.7) 1 1.0 (0.3–2.1)
COPD 4 0.8 (0.2–2.1) 5 0.9 (0.3–2.0) 7 1.4 (0.6–2.9) 0
Cirrhosis 8 1.6 (0.7–3.2) 2 0.4 (0–1.2) 1 0.2 (0–1.0) 1 0.3 (0–1.1)
Injury 7 1.4 (0.6–2.9) 7 1.2 (0.5–2.5) 2 0.3 (0–1.4) 3 0.8 (0.1–1.6)
Diabetes§ 3 0.6 (0.1–1.8) 4 0.7 (0.2–1.7) 0 0 0 0
Unknown† 3 0.6 (0.1–1.7) 3 0.5 (0.1–1.5) 0 0 1 0.4 (0–0.9)
All cause 181 36.9 (31.5–42.3) 157 27.1 (22.9–31.4) 72 13.3 (10.2–16.5) 28 9.2 (7.8–10.6)
95% CIs calculated using normal approximation from the SAS STDRATE procedure. COPD, chronic obstructive pulmonary disease; n, number of
persons or deaths in each group; pyrs, person-years. *Rates in NGT group are standardized directly to the age distribution of the corresponding NDD
group using the SAS STDRATE procedure; #number of deaths/1,000 person-years; §deaths from ketoacidosis or hyperosmolar coma; †unknown
causes.
Table 3—HRs for all-cause and CVD mortality in NDD compared with NGT with
adjustment for conventional cardiovascular risk factors
Variable adjusted HR 95% CI P
All-cause mortality in both sexes (438 deaths)
Unadjusted 3.7 2.9–4.1 ,0.0001
Age and sex 3.3 2.6–4.1 ,0.0001
Age, sex, BMI, SBP, Chol*, smoking, and previous CVD 3.1 2.4–3.9 ,0.0001
Among men (253 deaths)
Unadjusted 3.2 2.5–4.3 ,0.0001
Age 2.9 2.2–3.9 ,0.0001
Age, sex, BMI, SBP, Chol*, smoking, and previous CVD 2.6 1.9–3.5 ,0.0001
Among women (185 deaths)
Unadjusted 5.2 3.5–7.7 ,0.0001
Age 4.1 2.7–6.1 ,0.0001
Age, sex, BMI, SBP, Chol*, smoking, and previous CVD 4.1 2.7–6.3 ,0.0001
CVD mortality in both sexes (201 deaths)
Unadjusted 4.7 3.3–6.8 ,0.0001
Age and sex 4.2 2.9–6.0 ,0.0001
Age, sex, BMI, SBP, Chol*, smoking, and previous CVD 3.5 2.4–5.1 ,0.0001
Among men (115 deaths)
Unadjusted 3.8 2.5–5.8 ,0.0001
Age 3.4 2.2–5.3 ,0.0001
Age, sex, BMI, SBP, Chol*, smoking, and previous CVD 2.7 1.7–4.2 ,0.0001
Among women (86 deaths)
Unadjusted 8.9 4.3–16.5 ,0.0001
Age 6.9 3.3–14.4 ,0.0001
Age, sex, BMI, SBP, Chol*, smoking, and previous CVD 5.9 2.8–12.5 ,0.0001
HR and 95% CIs calculated using the the SAS PHREG procedure. Chol, total serum cholesterol.
*Multipoint imputation was used to estimate cholesterol levels in 218 individuals with missing
values.
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as in those of similar age without diabe-
tes. Another important ﬁnding is the ex-
tent to which diabetes resulted in
premature mortality. Almost 70% of
those with diabetes who died during
the study did so below 70 years of age.
The high proportion of people with di-
abetes who die during the active work-
ing and productive period of life has
major social and economic implications,
especially in view of the high and in-
creasing prevalence of diabetes in main-
land China. As excess deaths typically
occur some 20 years after the diagnosis
of diabetes and as the prevalence of di-
abetes in China has increased fourfold,
from 3% in 1990 to 12% in 2010, we pro-
ject that the number and proportion of
deaths attributable to diabetes will in-
crease considerably during the next 20
years.
Strengths and Limitations of Study
Our study had some notable strengths:
1) it was based on a population-based
cohort of Chinese adults with NDD iden-
tiﬁed by screening a well-deﬁned sam-
ple of the Da Qing city population; 2)
diabetes was diagnosed according to
the 1985 WHO criteria from systematic
OGTT testing, thus avoiding many of
the potential selection biases seen in
hospital and clinic-based studies; 3) par-
ticipants were of uniform ethnic back-
ground and most resided in the same
area during the follow-up period;
4) the comparison group had well-
documented NGT; 5) participants re-
ceived medical care representative of
that provided in China and most received
treatment from the same medical care
system throughout the study; 6) deaths
and cause of death were conﬁrmed by
review of their medical records in most
subjects; 7) participants were followed
for up to 23 years, thereby allowing suf-
ﬁcient time for the development of most
of the fatal long-term complications of
diabetes; and 8) few of the original par-
ticipants were lost to follow-up, thereby
minimizing nonresponse bias.
The study also had some important
limitations: 1) the NGT group, although
having the same age range as the group
with NDD, was on average younger and
contained fewer women (this disparity,
and the group’s small size, limits the
power of our analysis to detect dif-
ferences between the groups); 2)
participants were not reexamined
systematically at deﬁned intervals
throughout the follow-up, thereby obvi-
ating our ability to adjust for confound-
ing factors that may have changed over
time, although both the baseline exami-
nation and ﬁnal follow-up evaluations
were systematic; 3) not all deaths were
documented by death certiﬁcate but the
methodology used to determine the vital
status of participants has been used suc-
cessfully in other studies of mortality
rates in low- and middle-income coun-
tries, and we conﬁrmed deaths and their
causes by review of medical records; 4)
participants identiﬁed as having NDD
based on the OGTT results likely devel-
oped diabetes some time before the
diagnosis, resulting in some under-
estimation of the true duration of diabe-
tes; 5) 124 people in the NGT group
developed diabetes during the follow-
up period and 13 of them died during
the study (we did not censor follow-up
at time of diabetes diagnosis in these
subjects for our main analyses; this
may have led to some degree of under-
estimation of the excess risk of death
that we attributed to diabetes); and ﬁ-
nally, 6) the death rates we report are
necessarily retrospective and may have
Table 4—Age-speciﬁc all-cause death rates (per 1,000 person-years) in NDD by duration of diabetes and in NGT*
Duration (years)
Age-group (years)
25–49 50–59 60–69 70+ All ages
n/pyrs Rate n/pyrs Rate n/pyrs Rate n/pyrs Rate n/pyrs Rate
NDD
0–5 5/1,277 6.1 8/1,031 7.8 5/335 14.9 5/55 90.9 23/2,648 8.7
5–10 6/842 7.1 20/1,131 17.7 30/653 45.9 11/112 98.7 67/2,738 22.6
10–15 4/304 13.2 17/974 17.4 35/853 41.0 25/207 121.1 81/2,338 34.6
15+ 0/775 0.0 25/886 28.3 68/1,344 50.6 74/667 110.9 167/2,971 56.2
Total 15/2,450 6.1 70/4,021 17.4 138/3,185 43.3 115/1,040 110.6 338/10,695 31.6
NGT* 5/3,216 1.6 21/3,397 6.2 29/2,392 12.1 32/757 42.3 87/9,762 8.9
Fractional person-years rounded to whole numbers. n, number of deaths; pyrs, person-years. *Censored at diagnosis of diabetes in those with NGT.
Table 5—Age-speciﬁc CVD death rates (per 1,000 person-years) in NDD by duration of diabetes and in NGT*
Duration (years)
Age-group (years)
25–49 50–59 60–69 70+ All ages
n/pyrs Rate n/pyrs Rate n/pyrs Rate n/pyrs Rate n/pyrs Rate
NDD
0–5 0/1,228 0.0 3/1,031 2.9 1/335 3.0 2/55 36.7 6/2,648 2.3
5–10 3/842 3.6 11/1,132 9.7 19/653 29.1 7/112 62.8 40/2,738 14.6
10–15 2/304 6.6 9/974 9.2 20/853 23.4 6/207 29.1 37/2,338 15.8
15+ 0/77 0.0 10/884 11.3 40/1,344 29.8 31/667 46.5 81/2,971 27.3
Total 5/2,449 2.0 33/4,021 8.2 80/3,185 25.1 46/1,040 44.2 164/10,695 15.3
NGT* 3/3,216 0.9 7/3,397 2.1 10/2,392 4.2 11/757 14.5 31/9,762 3.2
Fractional person-years rounded to whole numbers. n, number of deaths; pyrs, person-years. *Censored at diagnosis of diabetes in those with NGT.
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changed due to improvements in medi-
cal care or other changing environmen-
tal factors.
Conclusion
Our study is the ﬁrst long-term,
population-based cohort study of
mortality and causes of death related
to diabetes in mainland China. It shows
that diabetes was associated with a sub-
stantially increased risk of death, espe-
cially from CVD, and that in both men
and women, almost half of this was
due to stroke. Our study can provide
more valid estimates of the excess
deaths that are attributable to diabetes
in mainland China and can be used to
predict the future mortality burden due
to diabetes for China.
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